US · Healthcare · Medical Care Facilities
EPS came in at 0.06 against a street estimate of 0.03 — a beat of 100.0%.
Analysts rate Lifestance Health Group Inc a buy (9 buy, 2 hold, 0 sell out of 11) with an average price target of $14.45.
CONFIDENT LifeStance beat Q2 guidance on 26% revenue growth and 15.2% EBITDA margins. Raised full-year outlook across metrics. Clinician base grew 11% to 8,542; productivity up 7% YoY for third consecutive quarter. Q2 2026 No regional breakdown provided. Geographic expansion strategy mentioned: presence in ~50% of 150 largest U.S. markets and 33 of 50 states. Analysts pressed on productivity sustainability, payer value-based arrangements, EHR disruption, M&A rationale, and AI rollout. Management emphasized 70% utilization headroom, constructive payer dialogue on outcomes, phased 2027 EHR transition with managed ramp, and disciplined tuck-in M&A for geographic entry. 2026-08-06…
Full summary in the app.
| Fund | Stake |
|---|---|
| TPG GP A, LLC | 29.39% |
| FMR Inc | 15.32% |
| BlackRock Inc | 9.56% |
| Summit Partners, LLP | 4.37% |
| Vanguard Portfolio Management, LLC | 3.67% |
| Jennison Associates LLC | 3.18% |
| Dimensional Fund Advisors, Inc. | 3.01% |
| Vanguard Capital Management, LLC | 2.56% |
| Document | Date |
|---|---|
| Quarterly report · Q3 2026 HEADLINE NUMBERS • Revenue was $455,864 thousand in Q3 2026, up from $363,809 thousand in Q3 2025. For the first nine months, revenue was $1,294,694 | 2026-11-05 |
| Results announced · Q4 2026 HEADLINE NUMBERS • Q3 2026 revenue was $455.9 million, up 25% from $363.8 million. • Net income was $22.4 million, compared with $1.1 million in Q3 | 2026-11-05 |
| Board / officer change · Q4 2026 OTHER NOTABLE POINTS • Teresa DeLuca, M.D. notified LifeStance Health Group’s board of directors on October 14, 2026, that she will resign from the b | 2026-10-16 |
| Company announcement · Q3 2026 LIFESTANCE HEALTH GROUP, INC. - 8-K SUMMARY HEADLINE NUMBERS • Share offering size: 22,250,000 shares of common stock sold by existing stockholders | 2026-09-11 |
| Quarterly report · Q2 2026 LIFESTANCE HEALTH GROUP, INC. – 10-Q SUMMARY Quarter Ended June 30, 2026 --- HEADLINE NUMBERS • Total Revenue (6 months): $838.8 million (up 23.7% | 2026-08-06 |
| Results announced · Q3 2026 LIFESTANCE HEALTH GROUP Q2 2026 EARNINGS SUMMARY HEADLINE NUMBERS • Revenue: $435.4 million in Q2 2026, up 26% from $345.3 million in Q2 2025 • Full | 2026-08-06 |
| Board / officer change · Q3 2026 LIFESTANCE HEALTH GROUP, INC. - 8-K SUMMARY HEADLINE NUMBERS • No financial metrics, revenue figures, or earnings data disclosed in this filing • Fi | 2026-07-07 |
| Shareholder vote results · Q2 2026 LIFESTANCE HEALTH GROUP, INC. - 8-K SUMMARY HEADLINE NUMBERS • Annual stockholder meeting held June 2, 2026 • Total votes cast for director election | 2026-06-04 |
Readable in the app.
| Announcement | Date |
|---|---|
| Full-year revenue, center margin, and adjusted EBITDA outlook raised LifeStance reported a strong third quarter for 2026. Revenue rose 25% year over year to $455.9 million, helped by a larger clinician base, higher productivity, 17% growth in visits to 2.7 mi | 2026-11-05 |
| Raises full year 2026 revenue, margin and EBITDA outlook LifeStance Health, a major mental healthcare provider, reported strong Q2 2026 results and raised its full-year outlook. Key highlights: Revenue grew 26% to $435.4 million (vs. $345.3 millio | 2026-08-06 |
| Full year 2026 revenue and EBITDA guidance raised on strong Q1 results LifeStance Health, a major mental healthcare provider, reported strong first-quarter 2026 results with revenue growing 21% to $403.5 million and net income surging from $0.7 million to $14.2 | 2026-05-07 |
| Board approves $100 million share repurchase program LifeStance Health, a major outpatient mental healthcare provider, reported strong 2025 results with 14% full-year revenue growth to $1.42 billion and 17% Q4 growth to $382 million. The compa | 2026-02-25 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Lifestance Health Group Inc — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-11-07.